(Q35800532)

10 August 2017

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma (English)

1 reference

10 August 2017

phase I clinical trial

0 references

1 reference

Nadine Martin-Duverneuil

7

object named as

Nadine Martin-Duverneuil

0 references

Florence Laigle-Donadey

2

object named as

Florence Laigle-Donadey

0 references

Marc Sanson

8

object named as

Marc Sanson

1 reference

10 August 2017

13

Jean-Yves Delattre

1 reference

10 August 2017

10

Sophie Taillibert

1 reference

10 August 2017

14

Antoine F Carpentier

1 reference

10 August 2017

Alexandre Carpentier

1

1 reference

10 August 2017

Sarah Zohar

3

1 reference

10 August 2017

Laurent Capelle

4

1 reference

10 August 2017

Anthony Behin

5

1 reference

10 August 2017

Annick Tibi

6

1 reference

10 August 2017

Lucette Lacomblez

9

1 reference

10 August 2017

Louis Puybasset

11

1 reference

10 August 2017

Remy Van Effenterre

12

1 reference

10 August 2017

1 January 2006

1 reference

10 August 2017

1 reference

10 August 2017

8

1 reference

10 August 2017

1

1 reference

10 August 2017

60-66

1 reference

Successful combination of local CpG-ODN and radiotherapy in malignant glioma

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Use of CpG oligodeoxynucleotides as immunoprotective agents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Response criteria for phase II studies of supratentorial malignant glioma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

25 September 2018

1 reference

12 December 2020

Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion

1 reference

12 December 2020

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

12 December 2020

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

12 December 2020

10.1215/S1522851705000475

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

16443949

1 reference